课题基金 / 基金详情

Corroborating the controversial Bilingual Advantage hypothesis using functional near infrared spectroscopy (fNIRS) neuroimaging

Corroborating the controversial Bilingual Advantage hypothesis using functional near infrared spectroscopy (fNIRS) neuroimaging
使用功能近红外光谱 (fNIRS) 神经影像学证实有争议的双语优势假说
批准号:
20K20152
负责人:
WROBLEWSKI GreggoryJohn
金额:
$2.08万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Early-Career Scientists
财政年份:
2020
资助国家:
日本
项目状态:
已结题
起止时间:
2020-04-01 至 2024-03-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
尽管COVID-19限制了研究,但越来越多的数据正在收集,以测试是否有证据证明有争议的双语优势假说,使用近红外光谱(NIRS)、口头流利性任务和表达性(英语)词汇测试相结合。到目前为止,我已经收集了6个参与者的数据,下周初还有两个参与者。此外,我还制定了用于在实际条件下收集数据的标准化协议,包括解决与设备维护、软件问题和参与者调度相关的潜在问题。
英文摘要
Despite COVID-19 restrictions to research, increasing data is being amassed to test whether there is evidence for the controversial bilingual advantage hypothesis using a combination of near-infrared spectroscopy (NIRS), a verbal fluency task, and an expressive (English) vocabulary test. I have managed to collect data from 6 participants so far, with two more scheduled for early next week. Additionally, I have standardized protocols for data collection in real-world conditions, including trouble-shooting potential problems associated with device maintenance, software issues, and participant scheduling.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
The Sarariman and the Stroller: An Exploration of a Seminal Work in the Ikumen Movement: Ikukyū Tōsan No Seichō Nisshi
《纱丽曼与婴儿车:对 Ikumen 运动开创性作品的探索:《育久同山的清张日》》
DOI: 10.15017/4736681
发表时间: 2021
期刊: 言語文化論究
影响因子: --
作者: [Wroblewski, G.]
通讯作者: G.
Cystectomy of Ovarian Borderline and Malignant Tumors for Fertility Sparing: Outcome of Seventeen Cases
卵巢交界性恶性肿瘤囊肿切除术保留生育能力:17例结果
DOI: 10.31579/2578-8965/079
发表时间: 2021
期刊: Journal of Obstetrics Gynecology and Reproductive Sciences
影响因子: --
作者: [Wroblewski J. , Takita M. , Eto H. , Yamamichi R. , Yoneda T. , Nishi D. , Matsuura T. , Maruyama T., Wroblewski G. , Kato S. , Muta A. , Sato S., Sanada S. , Nakayama T. , Okamoto D. and Sakai K.]
通讯作者: Okamoto D. and Sakai K.
海外基金